Glassia injection
Products billed under this code include Glassia.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Glassia.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Glassia | Takeda Pharmaceuticals America, Inc. | 00944-2884-01 | 0.1 | $0.564 |
| Glassia | Takeda Pharmaceuticals America, Inc. | 00944-2884-03 | 0.1 | $0.564 |
| Glassia | Takeda Pharmaceuticals America, Inc. | 00944-2884-05 | 0.1 | $0.564 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $5.64 | +$0.057 | 10 MG | Glassia injection | v1, posted September 17, 2026 |
| 3Q26 | $5.583 | −$0.077 | 10 MG | Glassia injection | v1, posted September 15, 2026 |
| 2Q26 | $5.66 | −$0.033 | 10 MG | Glassia injection | v1, posted September 15, 2026 |
| 1Q26 | $5.693 | +$0.054 | 10 MG | Glassia injection | v1, posted September 15, 2026 |
| 4Q25 | $5.639 | −$0.074 | 10 MG | Glassia injection | v1, posted September 8, 2026 |
| 3Q25 | $5.713 | +$0.265 | 10 MG | Glassia injection | v1, posted March 10, 2026 |
| 2Q25 | $5.448 | −$0.064 | 10 MG | Glassia injection | v1, posted March 10, 2026 |
| 1Q25 | $5.512 | −$0.064 | 10 MG | Glassia injection | v1, posted December 19, 2025 |
| 4Q24 | $5.576 | +$0.191 | 10 MG | Glassia injection | v1, posted June 11, 2025 |
| 3Q24 | $5.385 | −$0.01 | 10 MG | Glassia injection | v1, posted June 11, 2025 |
| 2Q24 | $5.395 | +$0.042 | 10 MG | Glassia injection | v1, posted March 11, 2025 |
| 1Q24 | $5.353 | −$0.064 | 10 MG | Glassia injection | v1, posted December 19, 2024 |
| 4Q23 | $5.417 | +$0.106 | 10 MG | Glassia injection | v1, posted October 10, 2024 |
| 3Q23 | $5.311 | +$0.159 | 10 MG | Glassia injection | v1, posted June 5, 2024 |
| 2Q23 | $5.152 | +$0.053 | 10 MG | Glassia injection | v1, posted February 23, 2024 |
| 1Q23 | $5.099 | −$0.084 | 10 MG | Glassia injection | v1, posted December 6, 2023 |
| 4Q22 | $5.183 | +$0.031 | 10 MG | Glassia injection | v1, posted June 22, 2023 |
| 3Q22 | $5.152 | +$0.181 | 10 MG | Glassia injection | v1, posted June 9, 2023 |
| 2Q22 | $4.971 | −$0.011 | 10 MG | Glassia injection | v1, posted December 14, 2022 |
| 1Q22 | $4.982 | +$0.032 | 10 MG | Glassia injection | v1, posted June 8, 2022 |
| 4Q21 | $4.95 | −$0.021 | 10 MG | Glassia injection | v1, posted June 2, 2022 |
| 3Q21 | $4.971 | +$0.106 | 10 MG | Glassia injection | v1, posted June 2, 2022 |
| 2Q21 | $4.865 | −$0.022 | 10 MG | Glassia injection | v1, posted March 1, 2022 |
| 1Q21 | $4.887 | – | 10 MG | Glassia injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.